<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:24:20Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9868384" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9868384</identifier>
        <datestamp>2023-01-23</datestamp>
        <setSpec>pheelsevier</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="brief-report" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Vaccine</journal-id>
              <journal-id journal-id-type="iso-abbrev">Vaccine</journal-id>
              <journal-title-group>
                <journal-title>Vaccine</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0264-410X</issn>
              <issn pub-type="epub">1873-2518</issn>
              <publisher>
                <publisher-name>The Author(s). Published by Elsevier Ltd.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9868384</article-id>
              <article-id pub-id-type="pmcid">PMC9868384</article-id>
              <article-id pub-id-type="pmc-uid">9868384</article-id>
              <article-id pub-id-type="pmid">36697314</article-id>
              <article-id pub-id-type="pii">S0264-410X(23)00061-0</article-id>
              <article-id pub-id-type="doi">10.1016/j.vaccine.2023.01.040</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Short Communication</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" id="au005">
                  <name>
                    <surname>Zolotarova</surname>
                    <given-names>Tetiana</given-names>
                  </name>
                  <xref rid="af005" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au010">
                  <name>
                    <surname>Dussault</surname>
                    <given-names>Camille</given-names>
                  </name>
                  <xref rid="af005" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au015">
                  <name>
                    <surname>Park</surname>
                    <given-names>Hyejin</given-names>
                  </name>
                  <xref rid="af005" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au020">
                  <name>
                    <surname>Varsaneux</surname>
                    <given-names>Olivia</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au025">
                  <name>
                    <surname>Basta</surname>
                    <given-names>Nicole E.</given-names>
                  </name>
                  <xref rid="af015" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author" id="au030">
                  <name>
                    <surname>Watson</surname>
                    <given-names>Lorena</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au035">
                  <name>
                    <surname>Robert</surname>
                    <given-names>Pennie</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au040">
                  <name>
                    <surname>Davis</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au045">
                  <name>
                    <surname>Mercer</surname>
                    <given-names>Morag</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au050">
                  <name>
                    <surname>Timmerman</surname>
                    <given-names>Samantha</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au055">
                  <name>
                    <surname>Bransfield</surname>
                    <given-names>Marla</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au060">
                  <name>
                    <surname>Minhas</surname>
                    <given-names>Michelle</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au065">
                  <name>
                    <surname>Kempis</surname>
                    <given-names>Raphael</given-names>
                  </name>
                  <xref rid="af010" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author" id="au070">
                  <name>
                    <surname>Kronfli</surname>
                    <given-names>Nadine</given-names>
                  </name>
                  <xref rid="af005" ref-type="aff">a</xref>
                  <xref rid="af020" ref-type="aff">d</xref>
                  <xref rid="cor1" ref-type="corresp">⁎</xref>
                </contrib>
                <aff id="af005"><label>a</label>Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada</aff>
                <aff id="af010"><label>b</label>Correctional Service Canada (CSC), Canada</aff>
                <aff id="af015"><label>c</label>Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada</aff>
                <aff id="af020"><label>d</label>Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>⁎</label>Corresponding author at: at: 1001 Decarie Boulevard, D02.4110 Montreal, Quebec H4A 3J1, Canada.</corresp>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>23</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
              <pub-date pub-type="ppub">
                <day>17</day>
                <month>2</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>23</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <volume>41</volume>
              <issue>8</issue>
              <fpage>1419</fpage>
              <lpage>1425</lpage>
              <history>
                <date date-type="received">
                  <day>22</day>
                  <month>12</month>
                  <year>2022</year>
                </date>
                <date date-type="rev-recd">
                  <day>13</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>17</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 The Author(s)</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license>
                  <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
                </license>
              </permissions>
              <abstract id="ab005">
                <p>Education is key to behavioural adoption and acceptability of health interventions. We evaluated the impact of an educational intervention administered 1:1 to individuals incarcerated in four Canadian federal prisons on COVID-19 vaccine uptake. Eligible individuals (those who had refused all COVID-19 vaccines) were randomized 2:1 to receive the educational intervention or not (control group); those who received the intervention completed questionnaires assessing COVID-19 vaccine-related knowledge, attitudes, and beliefs pre- and post-educational intervention. The primary and secondary outcome measures were COVID-19 vaccine uptake and vaccine confidence, respectively. Between May 3 and September 9, 2022, 202 participants were randomized to receive the intervention, of whom 127 (63 %) agreed to participate. Participants who were randomized to the intervention had higher COVID-19 vaccine uptake vs. the control group (5 % vs 1 %, p = 0.046). COVID-19 vaccine-related knowledge, attitudes, and beliefs improved post-intervention. Education increases COVID-19 vaccine uptake and confidence among people in Canadian federal correctional facilities.</p>
              </abstract>
              <kwd-group id="kg005">
                <title>Keywords</title>
                <kwd>Vaccine hesitancy</kwd>
                <kwd>Vaccine confidence</kwd>
                <kwd>Vaccine uptake</kwd>
                <kwd>Education</kwd>
                <kwd>COVID-19</kwd>
                <kwd>People in prison</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="s0005">
              <label>1</label>
              <title>Introduction</title>
              <p id="p0030">Canadian correctional facilities have been the epicentre of several large severe acute respiratory syndrome coronavirus (SARS-CoV-2) outbreaks since the beginning of the pandemic <xref rid="b0005" ref-type="bibr">[1]</xref>, <xref rid="b0010" ref-type="bibr">[2]</xref>, <xref rid="b0015" ref-type="bibr">[3]</xref>. As incarcerated individuals disproportionately experience social determinants of health associated with increased risk of COVID-19 due to a higher prevalence of chronic diseases such as hypertension and diabetes and, additionally, live in congregate settings with a high risk of transmission, efforts to maximize COVID-19 vaccine uptake, one of the most effective tools for reducing COVID-19 morbidity and mortality, are paramount. However, vaccine hesitancy is not uncommon among people in prison <xref rid="b0020" ref-type="bibr">[4]</xref>, <xref rid="b0025" ref-type="bibr">[5]</xref>, <xref rid="b0030" ref-type="bibr">[6]</xref>, <xref rid="b0035" ref-type="bibr">[7]</xref>, <xref rid="b0040" ref-type="bibr">[8]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0050" ref-type="bibr">[10]</xref>, <xref rid="b0055" ref-type="bibr">[11]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref>. Studies investigating reasons for vaccine refusal among people incarcerated in Canadian federal prisons found that a lack of information and misinformation were important barriers to COVID-19 vaccine acceptability <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref>, underscoring the potential for educational interventions to improve COVID-19 vaccine uptake.</p>
              <p id="p0035">Education is key to behavioural adoption and acceptability of health interventions. While the evaluation of educational interventions on COVID-19 vaccine uptake among incarcerated individuals has never been studied, various educational interventions have led to increased influenza <xref rid="b0065" ref-type="bibr">[13]</xref>, <xref rid="b0070" ref-type="bibr">[14]</xref>, human papillomavirus <xref rid="b0075" ref-type="bibr">[15]</xref>, and varicella-zoster virus vaccine uptake <xref rid="b0080" ref-type="bibr">[16]</xref>, and improvements in overall vaccine knowledge among adults in the general population <xref rid="b0085" ref-type="bibr">[17]</xref>. That said, studies have confirmed that prison vaccination programs have the potential to increase vaccine uptake if combined with education <xref rid="b0050" ref-type="bibr">[10]</xref>, <xref rid="b0055" ref-type="bibr">[11]</xref>. We thus aimed to evaluate the impact of an educational intervention on COVID-19 vaccine uptake among individuals incarcerated in Canadian federal prisons who had previously refused COVID-19 vaccination.</p>
            </sec>
            <sec id="s0010">
              <label>2</label>
              <title>Materials and methods</title>
              <sec id="s0015">
                <label>2.1</label>
                <title>Study design and setting</title>
                <p id="p0040">We conducted a prospective, randomized controlled study in four Canadian federal prisons. Prisons with the highest proportion of individuals who were never vaccinated against SARS-CoV-2 (25–31 %) prior to study inception were chosen as study sites from among the 43 federal prisons in Canada overseen by Correctional Service Canada (CSC) where incarcerated adults serve sentences of two years or more <xref rid="b0090" ref-type="bibr">[18]</xref>. This included four all-male institutions: Collins Bay Institution (CBI), Millhaven Institution (MI), and Joyceville Institution (JI) in Ontario and Kent Institution (KI) in British Columbia. Study site characteristics are shown in Supplementary Table 1. Study participation was voluntary and, as per CSC regulations <xref rid="b0095" ref-type="bibr">[19]</xref>, participants were not eligible to receive an honorarium or any incentive for their participation.</p>
              </sec>
              <sec id="s0020">
                <label>2.2</label>
                <title>Participants</title>
                <p id="p0045">As of April 20, 2021, incarcerated individuals across all 43 federal sites had access to an mRNA COVID-19 vaccine. We included individuals aged 18 years or older incarcerated at one of the four study sites who refused to be vaccinated against SARS-CoV-2 and who were able to consent to study participation in either English or French. Individuals who posed a security risk to the research team as determined by facility staff and anyone whose remaining sentence was less than one month were excluded from the study.</p>
              </sec>
              <sec id="s0025">
                <label>2.3</label>
                <title>Educational intervention</title>
                <p id="p0050">Building on our qualitative work identifying reasons for vaccine refusal among people incarcerated in Canadian federal prison <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref>, we consulted with an educational consultant to design an educational intervention tailored to addressing four primary reasons: 1. Risk perception; 2. Lack of knowledge (i.e. mRNA technology, efficacy, booster immunity); 3. Lack of trust; and 4. Perceived lack of benefits (personal and societal). The intervention was approved by CSC and the Indigenous Initiatives Directorate to ensure cultural sensitivity. It was designed to be administered 1:1 with visual aids and to be 15 minutes in duration (Supplementary Appendix A). To address issues of mistrust with CSC, a research assistant (unaffiliated with CSC) was trained to deliver the intervention. A facilitator guide was developed to answer potential questions and was validated by an Infectious Diseases specialist (NK) (Supplementary Appendix B).</p>
              </sec>
              <sec id="s0030">
                <label>2.4</label>
                <title>Data collection</title>
                <p id="p0055">The research assistant was provided with a de-identified list of potential participants at each study site. This was used to randomize individuals 2:1 into two groups, those who would be randomized to receive the intervention (Groups A and B; Group A being those who agreed to participate and Group B being those who declined) versus those who would not be contacted and who would serve as the control group (Group C). Eligible participants were approached by the research assistant near their units/ranges and were provided with a detailed description of the study. Participants who agreed to participate were escorted to a nearby interview room where written consent was documented. Participants were given two self-administered paper questionnaires to complete and those who required assistance with reading and writing could request support from the research assistant. The first questionnaire (the pre-intervention questionnaire (Supplementary Appendix C); ∼20 minutes) assessed socio-demographic and clinical characteristics, as well as knowledge, attitudes, and beliefs towards COVID-19 vaccines. We developed the survey questions by adapting questions from the World Health Organization Strategic Advisory Group of Experts Working Group on Vaccine Hesitancy <xref rid="b0100" ref-type="bibr">[20]</xref>, Leger’s North American Tracker – Concerns about COVID-19 <xref rid="b0105" ref-type="bibr">[21]</xref>, Statistics Canada’s Canadian Perspectives Survey Series 3 <xref rid="b0040" ref-type="bibr">[8]</xref>, the National Advisory Committee on Immunization Acceptability Matrix <xref rid="b0110" ref-type="bibr">[22]</xref>, an online survey of vaccine acceptability among the Canadian general public <xref rid="b0115" ref-type="bibr">[23]</xref>, and the 5C vaccine confidence scale <xref rid="b0120" ref-type="bibr">[24]</xref>. We pilot-tested the questionnaire with 15 people in prison to ensure clarity before study inception. Immediately following the pre-intervention questionnaire, the research assistant delivered the educational intervention to the participant 1:1. Thereafter, participants were given 10 minutes to ask questions. When questions were beyond the scope of the facilitator guide, participants were advised to consult their respective health care teams. A shorter post-intervention questionnaire (∼5 minutes; Supplementary Appendix D) was given immediately after the educational intervention. This questionnaire focused on knowledge, attitudes, and beliefs towards COVID-19 vaccines and participant willingness to accept vaccination. Following the post-intervention questionnaire, the research assistant offered an mRNA COVID-19 vaccine (Moderna Spikevax or Pfizer-BioNTech Comirnaty) to each participant and documented acceptance or refusal. Participants who accepted COVID-19 vaccination immediately following the intervention (“immediate uptake”) were then vaccinated by a CSC nurse as soon as possible. Participants who refused vaccination were approached 30 days later by the research assistant and re-offered vaccination (“delayed uptake” vs. “delayed refusal”). Individuals who declined participation (Group B) and incarcerated people in Group C who were not invited to participate were not exposed to the intervention. All individuals who declined vaccination in Group A and who remained unvaccinated in Groups B and C were offered a COVID-19 vaccine by CSC Infectious Disease nurses on a weekly basis. Anonymized baseline characteristics (age, ethnicity, results of SARS-CoV-2 testing during incarceration, and receipt of 2020–2021 influenza vaccine) and COVID-19 vaccination status were provided to the research team by CSC for those in Groups B and C at the end of study recruitment. This data was self-reported and collected in the pre-intervention questionnaire for Group A.</p>
                <p id="p0060">The recruitment period spanned five months (May 3 – September 9, 2022). Assuming a 2 % vaccine uptake rate among Group C without any intervention, a total sample size of 118 consented participants (Group A) and 59 participants in Group C was necessary to detect a 10 % increase in vaccination rate after the intervention with a level of significance of 0.05 and 80 % power versus <xref rid="b0125" ref-type="bibr">[25]</xref>. Given anticipated recruitment challenges and the likely degree of refusal to participate (estimated at 40 %), we increased the total sample size for Groups A and B to 200 participants total.</p>
              </sec>
              <sec id="s0035">
                <label>2.5</label>
                <title>Outcomes</title>
                <p id="p0065">The primary outcome measure was vaccine uptake, measured as the proportion of participants who accepted a COVID-19 vaccine following the educational intervention (“immediate” or “delayed” uptake). The secondary outcome measure was COVID-19 vaccine confidence, measured by changes to knowledge, attitudes, and beliefs post-educational intervention.</p>
              </sec>
              <sec id="s0040">
                <label>2.6</label>
                <title>Data analysis</title>
                <p id="p0070">Summary statistics were calculated to describe the study sample; continuous variables were reported in median and interquartile range (IQR), and categorical variables were reported in counts and proportions. The Mann-Whitney U and Pearson’s Chi-square tests were used to compare continuous and categorical variables, respectively. A p-value &lt; 0.05 was considered significant. For the primary outcome, an intention-to-treat (ITT) analysis with a two-sample <italic>Z</italic>-test of proportions was used to compare vaccine uptake between those randomized to receive the intervention (Groups A and B) vs. the control group (Group C), with a null hypothesis of no difference in population proportions against a one-sided alternative that vaccine uptake is greater among those who were randomized to receive the intervention compared to controls. A per-protocol (PP) sub-analysis with a two-sample <italic>Z</italic>-test of proportions was used to compare vaccine uptake between Groups A and C. For the secondary outcome, a paired sample <italic>t</italic>-test was used to compare the mean change in pre- and post-intervention vaccine confidence among participants who received the intervention. Questions measured using a Likert scale were scored out of 5: 1 = “strongly disagree,” 2 = “mostly disagree,” 3 = “uncertain,” 4 = “mostly agree,” and 5 = “strongly agree.” All analyses were performed using IBM SPSS (version 29.0).</p>
              </sec>
            </sec>
            <sec id="s0045">
              <label>3</label>
              <title>Results</title>
              <p id="p0075">Overall, 321 (of ∼ 1,120) individuals across the four study sites refused all prior COVID-19 vaccines. Of these, 303 met all eligibility criteria and were randomized 2:1 to the intervention or control groups, with 202 invited to participate in the study (<xref rid="f0005" ref-type="fig">Fig. 1</xref>
). A total of 61 (32 %) declined study participation (Group B) and 14 (7 %) were excluded, leaving 127 participants who agreed to receive the intervention (Group A).<fig id="f0005"><label>Fig. 1</label><caption><p>Study flowchart.</p></caption><graphic xlink:href="gr1_lrg"/></fig></p>
              <p id="p0080">Overall, the median age of participants was 31 years (<xref rid="t0005" ref-type="table">Table 1</xref>
). Over one-third (35 %) of participants self-identified as Black, 27 % as white, 11 % as Indigenous, and 24 % as another visible minority. The majority (75 %) had received a prior positive SARS-CoV-2 test and a minority (8 %) had received the 2020–2021 influenza vaccine during incarceration. Groups A and B were similar to Group C in terms of age, race/ethnicity, proportion who received the 2020–2021 influenza vaccine, and prison facility.<table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>Baseline characteristics of all study participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Characteristic</bold><break/></th><th><bold>Groups A and B</bold><break/>n = 188</th><th><bold>Group C</bold><break/>n = 101</th><th><bold>Total</bold><break/>N = 289</th><th><bold>p-value</bold></th></tr></thead><tbody><tr><td>Age, median (IQR), years</td><td>32 (11)</td><td>31 (12)</td><td>31 (12)</td><td>0.841</td></tr><tr><td colspan="5">Age category, n (%), years</td></tr><tr><td>18–29</td><td>71 (38)</td><td>43 (42)</td><td>114 (39)</td><td rowspan="4">0.021</td></tr><tr><td>30–39</td><td>75 (40)</td><td>36 (36)</td><td>111 (38)</td></tr><tr><td>40–49</td><td>33 (17)</td><td>9 (9)</td><td>42 (15)</td></tr><tr><td>≥50</td><td>9 (5)</td><td>13 (13)</td><td>22 (8)</td></tr><tr><td colspan="5">Race/ethnicity, n (%)</td></tr><tr><td>White, non-Hispanic</td><td>55 (29)</td><td>24 (24)</td><td>79 (27)</td><td rowspan="5">0.184</td></tr><tr><td>Black, non-Hispanic</td><td>58 (31)</td><td>44 (44)</td><td>102 (35)</td></tr><tr><td>Indigenous</td><td>25 (13)</td><td>7 (7)</td><td>32 (11)</td></tr><tr><td>Other visible minority</td><td>45 (24)</td><td>23 (23)</td><td>68 (24)</td></tr><tr><td>Missing data</td><td>5 (3)</td><td>3 (3)</td><td>8 (3)</td></tr><tr><td colspan="5">SARS-CoV-2 test result during incarceration, n (%)</td></tr><tr><td>Positive</td><td>118 (63)</td><td>98 (97)</td><td>216 (75)</td><td rowspan="3">&lt;0.001</td></tr><tr><td>Negative</td><td>58 (31)</td><td>3 (3)</td><td>61 (21)</td></tr><tr><td>Missing data</td><td>12 (6)</td><td>0</td><td>12 (4)</td></tr><tr><td colspan="5">Receipt of 2020–2021 influenza vaccine during incarceration, n (%)</td></tr><tr><td>Yes</td><td>17 (9)</td><td>7 (7)</td><td>24 (8)</td><td rowspan="3">0.445</td></tr><tr><td>No</td><td>160 (85)</td><td>94 (93)</td><td>254 (88)</td></tr><tr><td>Missing data</td><td>11(6)</td><td>0</td><td>11 (4)</td></tr><tr><td colspan="5">Correctional facility, n (%)</td></tr><tr><td>CBI</td><td>73 (39)</td><td>38 (37)</td><td>111 (38)</td><td rowspan="4">0.962</td></tr><tr><td>JI</td><td>63 (33)</td><td>34 (34)</td><td>97 (34)</td></tr><tr><td>KI</td><td>28 (15)</td><td>14 (14)</td><td>42 (15)</td></tr><tr><td>MI</td><td>24 (13)</td><td>15 (15)</td><td>39 (13)</td></tr></tbody></table><table-wrap-foot><fn><p>CBI: Collins Bay Institution; IQR: interquartile range; JI: Joyceville Institution; KI: Kent Institution; MI: Millhaven Institution.</p></fn></table-wrap-foot></table-wrap></p>
              <p id="p0085">A total of 9 participants (5 %) in Groups A and B (n = 9 in Group A; n = 9 immediate uptake) and one (1 %) individual in Group C agreed to be vaccinated (Supplementary Fig. 1). Median time to receipt of vaccine was 1 day (range = 1 – 8). Among these, 3 (33 %) self-identified as Black, 3 (33 %) as white, 2 (22 %) as another visible minority, and 1 (11 %) as Indigenous (data not shown). In the ITT analysis, participants randomized to the intervention group (Groups A and B) had a higher COVID-19 vaccine uptake compared to participants in the control group (<italic>z</italic> = 1.68, <italic>p</italic> = 0.046), at a 5 % level of significance. In the PP sub-analysis, participants in Group A had a higher COVID-19 vaccine uptake (9/127; 7 %) than participants in Group C (<italic>z</italic> = 2.23, <italic>p</italic> = 0.013), at a 5 % level of significance. Primary reasons for immediate vaccine refusal post-intervention included “lack of trust” (n = 40; 34 %), “lack of knowledge” (n = 29; 25 %), and “lack of benefits” (n = 13; 11 %) (Supplementary Fig. 2).</p>
              <p id="p0090">All participants in Group A completed both questionnaires. The distribution of knowledge, attitudes, and beliefs towards COVID-19 vaccination and the change in means between pre- and post-intervention questionnaire responses are presented in <xref rid="f0010" ref-type="fig">Fig. 2</xref>
and <xref rid="t0010" ref-type="table">Table 2</xref>
, respectively. Following the educational intervention, there were significant improvements in knowledge and more favourable attitudes and beliefs towards COVID-19 vaccines. There were no improvements in participants’ perception of the COVID-19 pandemic as a real threat and the risk of COVID-19 in prisons.<fig id="f0010"><label>Fig. 2</label><caption><p>Pre- and post-intervention distribution of knowledge, attitudes, and beliefs among participants who received the educational intervention (Group A). Each questionnaire item was classified into one of the four primary reasons for vaccine refusal among people in federal prisons addressed during the educational intervention (i.e., I. Risk perception; II. Lack of knowledge; II. Lack of trust; and IV. Perceived lack of benefits).</p></caption><graphic xlink:href="gr2_lrg"/></fig><table-wrap position="float" id="t0010"><label>Table 2</label><caption><p>Changes in knowledge, attitudes and beliefs among participants who received the educational intervention (Group A).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Survey item</th><th colspan="2">Mean<hr/></th><th rowspan="2">Change</th><th colspan="2">95 % CI<hr/></th><th rowspan="2">sd</th><th rowspan="2">p-value</th></tr><tr><th>Pre</th><th>Post</th><th>Lower</th><th>Upper</th></tr></thead><tbody><tr><td colspan="8"><list list-type="simple" id="l0005"><list-item id="o0005"><label>I.</label><p id="p0005">Risk perception</p></list-item></list></td></tr><tr><td>I believe the COVID-19 pandemic is a real threat<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td align="char">3.57</td><td align="char">3.69</td><td align="char">0.12</td><td align="char">−0.061</td><td align="char">0.297</td><td align="char">1.021</td><td align="char">0.195</td></tr><tr><td>I am personally worried about getting COVID-19<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td align="char">2.02</td><td align="char">2.42</td><td align="char">0.39</td><td align="char">0.229</td><td align="char">0.558</td><td align="char">0.936</td><td align="char">&lt;0.001</td></tr><tr><td>I believe I am at risk of becoming hospitalized or dying from COVID-19<xref rid="tblfn2" ref-type="table-fn">b</xref></td><td align="char">2.18</td><td align="char">2.46</td><td align="char">0.28</td><td align="char">0.129</td><td align="char">0.438</td><td align="char">0.881</td><td align="char">&lt;0.001</td></tr><tr><td>People in prison should be prioritized for COVID-19 vaccination<xref rid="tblfn2" ref-type="table-fn">b</xref></td><td align="char">2.80</td><td align="char">3.13</td><td align="char">0.33</td><td align="char">0.191</td><td align="char">0.471</td><td align="char">0.797</td><td align="char">&lt;0.001</td></tr><tr><td>I believe the risk of COVID-19 is small in prisons<xref rid="tblfn3" ref-type="table-fn">c</xref></td><td align="char">2.50</td><td align="char">2.36</td><td align="char">−0.14</td><td align="char">−0.352</td><td align="char">0.084</td><td align="char">1.243</td><td align="char">0.227</td></tr><tr><td colspan="8"><list list-type="simple" id="l0010"><list-item id="o0010"><label>II.</label><p id="p0010">Lack of knowledge</p></list-item></list></td></tr><tr><td>There is a need for COVID-19 vaccines during this pandemic<xref rid="tblfn2" ref-type="table-fn">b</xref></td><td align="char">3.06</td><td align="char">3.48</td><td align="char">0.42</td><td align="char">0.256</td><td align="char">0.594</td><td align="char">0.964</td><td align="char">&lt;0.001</td></tr><tr><td>Overall I think the COVID-19 vaccines available in Canada are effective<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">2.55</td><td align="char">3.03</td><td align="char">0.48</td><td align="char">0.323</td><td align="char">0.638</td><td align="char">0.898</td><td align="char">&lt;0.001</td></tr><tr><td>Overall I think the COVID-19 vaccines available in Canada are safe<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">2.64</td><td align="char">3.02</td><td align="char">0.38</td><td align="char">0.226</td><td align="char">0.545</td><td align="char">0.909</td><td align="char">&lt;0.001</td></tr><tr><td>I am concerned about serious side effects of the COVID-19 vaccines<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">3.96</td><td align="char">3.66</td><td align="char">−0.3</td><td align="char">−0.554</td><td align="char">−0.045</td><td align="char">1.449</td><td align="char">0.022</td></tr><tr><td>Getting vaccinated against COVID-19 is a good way to protect myself from this disease<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">2.55</td><td align="char">3.03</td><td align="char">0.48</td><td align="char">0.323</td><td align="char">0.638</td><td align="char">0.898</td><td align="char">&lt;0.001</td></tr><tr><td colspan="8"><list list-type="simple" id="l0015"><list-item id="o0015"><label>III.</label><p id="p0015">Lack of trust</p></list-item></list></td></tr><tr><td>When COVID-19 vaccines are offered by CSC, they will be beneficial<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">2.80</td><td align="char">3.19</td><td align="char">0.39</td><td align="char">0.228</td><td align="char">0.544</td><td align="char">0.900</td><td align="char">&lt;0.001</td></tr><tr><td>The information I receive about COVID-19 vaccines from CSC healthcare workers is reliable and trustworthy<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">2.86</td><td align="char">3.23</td><td align="char">0.37</td><td align="char">0.202</td><td align="char">0.538</td><td align="char">0.958</td><td align="char">&lt;0.001</td></tr><tr><td colspan="8"><list list-type="simple" id="l0020"><list-item id="o0020"><label>IV.</label><p id="p0020">Perceived lack of benefits</p></list-item></list></td></tr><tr><td>Getting vaccinated is important for the health of others in prison<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">2.96</td><td align="char">3.37</td><td align="char">0.41</td><td align="char">0.251</td><td align="char">0.568</td><td align="char">0.903</td><td align="char">&lt;0.001</td></tr><tr><td>People should get vaccinated to prevent the spread of COVID-19 in prison<xref rid="tblfn5" ref-type="table-fn">e</xref></td><td align="char">2.69</td><td align="char">3.24</td><td align="char">0.55</td><td align="char">0.405</td><td align="char">0.697</td><td align="char">0.833</td><td align="char">&lt;0.001</td></tr><tr><td>Getting vaccinated is important for the health of others in the community (outside of prison)<xref rid="tblfn4" ref-type="table-fn">d</xref></td><td align="char">3.02</td><td align="char">3.37</td><td align="char">0.35</td><td align="char">0.224</td><td align="char">0.484</td><td align="char">0.740</td><td align="char">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="sp0035"><p>Questionnaire item: Average score out of 5 (1 = “strongly disagree”, 2 = “mostly disagree”, 3 = “uncertain”, 4 = “mostly agree”, 5 = “strongly agree”).</p></fn><fn id="sp0040"><p>CI: confidence interval; CSC: Correctional Service Canada; sd: standard deviation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="np005">Leger’s North American Tracker – Concerns about COVID-19.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn2"><label>b</label><p id="np010">National Advisory Committee on Immunization Acceptability Matrix.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn3"><label>c</label><p id="np015">5C scale.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn4"><label>d</label><p id="np020">World Health Organization Strategic Advisory Group of Experts Working Group on Vaccine Hesitancy.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn5"><label>e</label><p id="np025">Online survey of vaccine acceptability among the Canadian general public.</p></fn></table-wrap-foot></table-wrap></p>
            </sec>
            <sec id="s0050">
              <label>4</label>
              <title>Discussion</title>
              <p id="p0095">This prospective, randomized controlled study evaluated the impact of an educational intervention – tailored to the reasons for vaccine refusal identified by people in federal prison – on COVID-19 vaccine uptake and confidence among individuals incarcerated in four Canadian federal prisons that had the highest proportion of COVID-19 vaccine refusal at a time when vaccines were freely and readily available in prisons. We found that those who received the educational intervention experienced a small but statistically significant increase in vaccine uptake, improvements in COVID-19 vaccine-related knowledge, and more favourable attitudes and beliefs towards COVID-19 vaccines. Our results are in line with other studies that have demonstrated modest increases in vaccine uptake <xref rid="b0130" ref-type="bibr">[26]</xref> and vaccine acceptability <xref rid="b0135" ref-type="bibr">[27]</xref> following educational interventions, underscoring that while education is inarguably important, a multimodal approach that incorporates education alongside or in addition to other interventions will be essential for increasing vaccination among vaccine-hesitant incarcerated individuals.</p>
              <p id="p0100">Interestingly, the educational intervention had an immediate effect on vaccine uptake but failed to influence COVID-19 vaccine uptake 30 days post-intervention. Sun et al. <xref rid="b0140" ref-type="bibr">[28]</xref> showed that intermittent long-term education is needed to maintain motivation and encourage behaviour adoption for vaccination, suggesting that additional educational sessions (or other interventions) may have been necessary to address reasons for ongoing hesitancy over time. Furthermore, we previously found that incarcerated individuals’ attitudes towards vaccination are often influenced by their support systems <xref rid="b0060" ref-type="bibr">[12]</xref>, implying that educational approaches such as ones that expand the provision of information to outside support networks may be one novel approach to improving vaccine uptake in prison settings <xref rid="b0145" ref-type="bibr">[29]</xref>.</p>
              <p id="p0105">Addressing distrust, the primary reason we identified for immediate vaccine refusal after the educational intervention, will be an essential component of improving COVID-19 vaccine uptake among people in prison. Cognizant of the challenges in building trusting relationships between correctional staff and people in prison, the intervention was intentionally delivered by an individual unaffiliated with the prison system to provide participants with an independent source of information. Nonetheless, the majority (93 %) of participants refused COVID-19 vaccination post-intervention, with one-third declining vaccination due to a lack of trust. Providing information, educational content, and messaging about vaccines from a trusted source has been identified as a key component of successful interventions. For example, to further foster provider-patient trust, studies have shown that providers who adopt dialogue-based approaches or campaigns that involve leaders and peers result in higher vaccine uptake <xref rid="b0150" ref-type="bibr">[30]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>. In federal corrections, trusted individuals could include Indigenous Elders or prison committee members. Consideration should be given to the implementation of “inmate volunteer” models of care where incarcerated individuals take more active roles in prison health care delivery. These models have had positive effects on trust-building and the empowerment of people in prison <xref rid="b0160" ref-type="bibr">[32]</xref>, and may improve vaccine uptake going forward.</p>
              <p id="p0110">Our study has limitations. First, our study was conducted in four of 43 Canadian federal correctional facilities where all incarcerated people were male, thereby decreasing the generalizability of our results to other correctional institutions or to those who house women. That said, gender has not been found to predict vaccine uptake in prior studies utilizing educational interventions <xref rid="b0065" ref-type="bibr">[13]</xref>, <xref rid="b0165" ref-type="bibr">[33]</xref>, <xref rid="b0170" ref-type="bibr">[34]</xref>. Second, we made the assumption that the reasons for vaccine refusal identified during prior qualitative research conducted among this population <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref> were generalizable to the entire federal incarcerated population. Ideally, we would have conducted qualitative interviews in each of the selected sites prior to recruitment and tailored the education intervention accordingly. Third, baseline characteristics of study participants presented in <xref rid="t0005" ref-type="table">Table 1</xref> were self-reported for Group A only. Despite these limitations, this is the first study to evaluate the effect of an educational intervention on COVID-19 vaccine uptake among incarcerated people who had refused COVID-19 vaccination and adds to the dearth of literature regarding the role of education in improving vaccine uptake and confidence.</p>
            </sec>
            <sec id="s0055">
              <label>5</label>
              <title>Conclusions</title>
              <p id="p0115">Education increases COVID-19 vaccine uptake and confidence among people in Canadian federal correctional facilities. Future efforts should seek to involve people in prison in both the co-design and delivery of prison-based educational tools to address multiple barriers to vaccination and ultimately improve COVID-19 vaccine uptake and confidence.</p>
            </sec>
            <sec id="s0060">
              <label>6</label>
              <title>Statement of ethics</title>
              <p id="p0120">The study was approved by the McGill University Health Centre Research Ethics Board (REB #2022 – 7868).</p>
            </sec>
            <sec id="s0065">
              <title>Funding</title>
              <p id="p0125">This work was supported by a CIHR Operating Grant: COVID-19 Vaccine Confidence awarded to NK. NEB is supported by a Canada Research Chair Tier 2 in Infectious Disease Prevention. NK is supported by a career award from the Fonds de Recherche Québec – Santé (FRQ-S Junior 1).</p>
            </sec>
            <sec sec-type="COI-statement">
              <title>Declaration of Competing Interest</title>
              <p id="p0130">The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [TZ, HP, CD, OV, NEB, LW, PR, SD, MM, ST, MB, MM and RK have no conflicts of interest to declare. NK reports research funding from Gilead Sciences, advisory fees from Gilead Sciences, ViiV Healthcare, Merck and Abbvie, and speaker fees from Gilead Sciences and Merck.].</p>
            </sec>
          </body>
          <back>
            <ref-list id="bi005">
              <title>References</title>
              <ref id="b0005">
                <label>1</label>
                <mixed-citation publication-type="other" id="h0005">Correctional Service Canada. Testing of inmates in federal correctional institutions for COVID-19. Test Inmates Fed Correct Institutions COVID-19 n.d. <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/correctional-service/campaigns/covid-19/inmate-testing.html" id="ir010">https://www.canada.ca/en/correctional-service/campaigns/covid-19/inmate-testing.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="b0010">
                <label>2</label>
                <element-citation publication-type="journal" id="h0010">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kronfli</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Dussault</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Maheu-Giroux</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Halavrezos</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Chalifoux</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sherman</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021</article-title>
                  <source>Clin Infect Dis</source>
                  <volume>75</volume>
                  <year>2022</year>
                  <fpage>e165</fpage>
                  <lpage>e173</lpage>
                  <pub-id pub-id-type="doi">10.1093/cid/ciac031</pub-id>
                  <pub-id pub-id-type="pmid">35037053</pub-id>
                </element-citation>
              </ref>
              <ref id="b0015">
                <label>3</label>
                <element-citation publication-type="journal" id="h0015">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kronfli</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Dussault</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Maheu-Giroux</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Halavrezos</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Chalifoux</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Importance of occupation for SARS-CoV-2 seroprevalence and COVID-19 vaccination among correctional workers in Quebec, Canada: A cross-sectional study</article-title>
                  <source>Front Public Heal</source>
                  <year>2022</year>
                  <fpage>10</fpage>
                  <pub-id pub-id-type="doi">10.3389/fpubh.2022.1021871</pub-id>
                </element-citation>
              </ref>
              <ref id="b0020">
                <label>4</label>
                <element-citation publication-type="journal" id="h0020">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Madeddu</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Vroling</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Oordt-Speets</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Babudieri</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>O’Moore</surname>
                      <given-names>É.</given-names>
                    </name>
                    <name>
                      <surname>Noordegraaf</surname>
                      <given-names>M.V.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries</article-title>
                  <source>Vaccine</source>
                  <volume>37</volume>
                  <year>2019</year>
                  <fpage>4906</fpage>
                  <lpage>4919</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.07.014</pub-id>
                  <pub-id pub-id-type="pmid">31327651</pub-id>
                </element-citation>
              </ref>
              <ref id="b0025">
                <label>5</label>
                <element-citation publication-type="journal" id="h0025">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kronfli</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Akiyama</surname>
                      <given-names>M.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Prioritizing incarcerated populations for COVID-19 vaccination and vaccine trials</article-title>
                  <source>EClinicalMedicine</source>
                  <volume>31</volume>
                  <year>2021</year>
                  <fpage>2020</fpage>
                  <lpage>2021</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.eclinm.2020.100659</pub-id>
                </element-citation>
              </ref>
              <ref id="b0030">
                <label>6</label>
                <element-citation publication-type="journal" id="h0030">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Zenilman</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Brinkley-Rubinstein</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities</article-title>
                  <source>JAMA</source>
                  <volume>324</volume>
                  <year>2020</year>
                  <fpage>1031</fpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2020.15589</pub-id>
                  <pub-id pub-id-type="pmid">32808972</pub-id>
                </element-citation>
              </ref>
              <ref id="b0035">
                <label>7</label>
                <element-citation publication-type="journal" id="h0035">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vicente-Alcalde</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Ruescas-Escolano</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Harboe</surname>
                      <given-names>Z.B.</given-names>
                    </name>
                    <name>
                      <surname>Tuells</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Vaccination coverage among prisoners: A systematic review</article-title>
                  <source>Int J Environ Res Public Health</source>
                  <volume>17</volume>
                  <year>2020</year>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.3390/ijerph17207589</pub-id>
                </element-citation>
              </ref>
              <ref id="b0040">
                <label>8</label>
                <element-citation publication-type="journal" id="h0040">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Romanchuk</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Linthwaite</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Dussault</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Basta</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Determinants of SARS-CoV-2 vaccine willingness among people incarcerated in 3 Canadian federal prisons: a cross-sectional study</article-title>
                  <source>C Open</source>
                  <volume>10</volume>
                  <year>2022</year>
                  <fpage>E922</fpage>
                  <lpage>E929</lpage>
                  <pub-id pub-id-type="doi">10.9778/cmajo.20210248</pub-id>
                </element-citation>
              </ref>
              <ref id="b0045">
                <label>9</label>
                <element-citation publication-type="journal" id="h0045">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lessard</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Ortiz-Paredes</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Varsaneux</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Worthington</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Basta</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Barriers and facilitators to COVID-19 vaccine acceptability among people incarcerated in Canadian federal prisons: A qualitative study</article-title>
                  <source>Vaccine X</source>
                  <volume>10</volume>
                  <year>2022</year>
                  <object-id pub-id-type="publisher-id">100150</object-id>
                  <pub-id pub-id-type="doi">10.1016/j.jvacx.2022.100150</pub-id>
                </element-citation>
              </ref>
              <ref id="b0050">
                <label>10</label>
                <element-citation publication-type="journal" id="h0050">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buck</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Morrow</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Margolis</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Eldridge</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Sosman</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>MacGowan</surname>
                      <given-names>R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Hepatitis B Vaccination in Prison: The Perspectives of Formerly Incarcerated Men</article-title>
                  <source>J Correct Heal Care</source>
                  <volume>12</volume>
                  <year>2006</year>
                  <fpage>12</fpage>
                  <lpage>23</lpage>
                  <pub-id pub-id-type="doi">10.1177/1078345806287937</pub-id>
                </element-citation>
              </ref>
              <ref id="b0055">
                <label>11</label>
                <element-citation publication-type="journal" id="h0055">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Devine</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Karvelas</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Sundararajan</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of a prison-based hepatitis B immunisation pilot project</article-title>
                  <source>Aust N Z J Public Health</source>
                  <volume>31</volume>
                  <year>2007</year>
                  <fpage>127</fpage>
                  <lpage>130</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1753-6405.2007.00029.x</pub-id>
                  <pub-id pub-id-type="pmid">17461002</pub-id>
                </element-citation>
              </ref>
              <ref id="b0060">
                <label>12</label>
                <element-citation publication-type="journal" id="h0060">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ortiz-Paredes</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Varsaneux</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Worthington</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>MacDonald</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Basta</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons</article-title>
                  <source>PLoS One</source>
                  <volume>17</volume>
                  <year>2022</year>
                  <fpage>1</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0264145</pub-id>
                </element-citation>
              </ref>
              <ref id="b0065">
                <label>13</label>
                <element-citation publication-type="journal" id="h0065">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leung</surname>
                      <given-names>K.C.</given-names>
                    </name>
                    <name>
                      <surname>Mui</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chiu</surname>
                      <given-names>W.Y.</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>Y.Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>M.H.Y.</given-names>
                    </name>
                    <name>
                      <surname>Ho</surname>
                      <given-names>P.H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of patient education on influenza vaccine uptake among community-dwelling elderly: A randomized controlled trial</article-title>
                  <source>Health Educ Res</source>
                  <volume>32</volume>
                  <year>2017</year>
                  <fpage>455</fpage>
                  <lpage>464</lpage>
                  <pub-id pub-id-type="doi">10.1093/her/cyx053</pub-id>
                  <pub-id pub-id-type="pmid">28931164</pub-id>
                </element-citation>
              </ref>
              <ref id="b0070">
                <label>14</label>
                <element-citation publication-type="journal" id="h0070">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wong</surname>
                      <given-names>V.W.Y.</given-names>
                    </name>
                    <name>
                      <surname>Fong</surname>
                      <given-names>D.Y.T.</given-names>
                    </name>
                    <name>
                      <surname>Lok</surname>
                      <given-names>K.Y.W.</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>J.Y.H.</given-names>
                    </name>
                    <name>
                      <surname>Sing</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>A.Y.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial</article-title>
                  <source>Vaccine</source>
                  <volume>34</volume>
                  <year>2016</year>
                  <fpage>5243</fpage>
                  <lpage>5250</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.09.019</pub-id>
                  <pub-id pub-id-type="pmid">27667330</pub-id>
                </element-citation>
              </ref>
              <ref id="b0075">
                <label>15</label>
                <element-citation publication-type="journal" id="h0075">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Piedimonte</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Zakhari</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Giordano</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Tellier</surname>
                      <given-names>P.-P.</given-names>
                    </name>
                    <name>
                      <surname>Lau</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of an HPV Education and Vaccination Campaign among Canadian University Students</article-title>
                  <source>J Obstet Gynaecol Canada</source>
                  <volume>40</volume>
                  <year>2018</year>
                  <fpage>440</fpage>
                  <lpage>446</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jogc.2017.07.028</pub-id>
                </element-citation>
              </ref>
              <ref id="b0080">
                <label>16</label>
                <element-citation publication-type="journal" id="h0080">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of two health education interventions to improve the varicella vaccination: A randomized controlled trial from a province in the east China</article-title>
                  <source>BMC Public Health</source>
                  <volume>18</volume>
                  <year>2018</year>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-018-5070-0</pub-id>
                </element-citation>
              </ref>
              <ref id="b0085">
                <label>17</label>
                <element-citation publication-type="journal" id="h0085">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carolan</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Verran</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Crossley</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Redfern</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Whitton</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Amos</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: A pilot study</article-title>
                  <source>PLoS One</source>
                  <volume>13</volume>
                  <year>2018</year>
                  <fpage>1</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0190984</pub-id>
                </element-citation>
              </ref>
              <ref id="b0090">
                <label>18</label>
                <mixed-citation publication-type="other" id="h0090">Government of Canada. Vaccines administered to inmates in the federal correctional system n.d. <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/correctional-service/campaigns/covid-19/vaccine-csc/vaccine-table.html" id="ir015">https://www.canada.ca/en/correctional-service/campaigns/covid-19/vaccine-csc/vaccine-table.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="b0095">
                <label>19</label>
                <mixed-citation publication-type="other" id="h0095">Correctional Service Canada. Commissioner’s Directives 009 Research n.d. <ext-link ext-link-type="uri" xlink:href="https://www.csc-scc.gc.ca/lois-et-reglements/009-cd-en.shtml" id="ir020">https://www.csc-scc.gc.ca/lois-et-reglements/009-cd-en.shtml</ext-link>.</mixed-citation>
              </ref>
              <ref id="b0100">
                <label>20</label>
                <element-citation publication-type="journal" id="h0100">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Larson</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Jarrett</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>W.S.</given-names>
                    </name>
                    <name>
                      <surname>Chaudhuri</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Dube</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Measuring vaccine hesitancy: The development of a survey tool</article-title>
                  <source>Vaccine</source>
                  <volume>33</volume>
                  <year>2015</year>
                  <fpage>4165</fpage>
                  <lpage>4175</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.04.037</pub-id>
                  <pub-id pub-id-type="pmid">25896384</pub-id>
                </element-citation>
              </ref>
              <ref id="b0105">
                <label>21</label>
                <mixed-citation publication-type="other" id="h0105">Concerns About COVID-19 – March 24, 2020. Leger 2020 Mar 24 2020. <ext-link ext-link-type="uri" xlink:href="https://legermarketing.wpenginepowered.com/wp-content/uploads/2020/03/COVID-19-Tracking-Study-March-24-2020-final.pdf" id="ir025">https://legermarketing.wpenginepowered.com/wp-content/uploads/2020/03/COVID-19-Tracking-Study-March-24-2020-final.pdf</ext-link> (accessed November 8, 2022).</mixed-citation>
              </ref>
              <ref id="b0110">
                <label>22</label>
                <element-citation publication-type="journal" id="h0110">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ismail</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Hardy</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Tunis</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Sicard</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Quach</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations</article-title>
                  <source>Vaccine</source>
                  <volume>38</volume>
                  <year>2020</year>
                  <fpage>5861</fpage>
                  <lpage>5876</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2020.05.051</pub-id>
                  <pub-id pub-id-type="pmid">32532544</pub-id>
                </element-citation>
              </ref>
              <ref id="b0115">
                <label>23</label>
                <mixed-citation publication-type="other" id="h0115">Environics Research. Vaccine Acceptability Factors for the General Public and Health Care Professionals in Canada. 2020;50:99. <ext-link ext-link-type="uri" xlink:href="https://publications.gc.ca/collections/collection_2020/sc-hc/H14-339-2020-1-eng.pdf" id="ir030">https://publications.gc.ca/collections/collection_2020/sc-hc/H14-339-2020-1-eng.pdf</ext-link>.</mixed-citation>
              </ref>
              <ref id="b0120">
                <label>24</label>
                <element-citation publication-type="journal" id="h0120">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Betsch</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schmid</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Heinemeier</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Korn</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Holtmann</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Böhm</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <source>Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination</source>
                  <volume>vol. 13</volume>
                  <year>2018</year>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0208601</pub-id>
                </element-citation>
              </ref>
              <ref id="b0125">
                <label>25</label>
                <mixed-citation publication-type="other" id="h0125">Statulator. Sample Size Calculator for Comparing Two Independent Proportions n.d. <ext-link ext-link-type="uri" xlink:href="https://statulator.com/SampleSize/ss2P.html" id="ir035">https://statulator.com/SampleSize/ss2P.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="b0130">
                <label>26</label>
                <element-citation publication-type="journal" id="h0130">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Winter</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Kinner</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Stoové</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Guy</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hellard</surname>
                      <given-names>M.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>A nurse-led intervention improved blood-borne virus testing and vaccination in Victorian prisons</article-title>
                  <source>Aust N Z J Public Health</source>
                  <volume>40</volume>
                  <year>2016</year>
                  <fpage>592</fpage>
                  <lpage>594</lpage>
                  <pub-id pub-id-type="doi">10.1111/1753-6405.12578</pub-id>
                  <pub-id pub-id-type="pmid">27774690</pub-id>
                </element-citation>
              </ref>
              <ref id="b0135">
                <label>27</label>
                <element-citation publication-type="journal" id="h0135">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaim</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Siman-Tov</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Jaffe</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Adini</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of a Concise Educational Program on COVID-19 Vaccination Attitudes</article-title>
                  <source>Front Public Heal</source>
                  <year>2021</year>
                  <fpage>9</fpage>
                  <pub-id pub-id-type="doi">10.3389/fpubh.2021.767447</pub-id>
                </element-citation>
              </ref>
              <ref id="b0140">
                <label>28</label>
                <element-citation publication-type="journal" id="h0140">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sun</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-term effect of mobile phone-based education and influencing factors of willingness to receive HPV vaccination among female freshmen in Shanxi Province, China</article-title>
                  <source>Hum Vaccin Immunother</source>
                  <year>2022</year>
                  <fpage>18</fpage>
                  <pub-id pub-id-type="doi">10.1080/21645515.2022.2051990</pub-id>
                </element-citation>
              </ref>
              <ref id="b0145">
                <label>29</label>
                <mixed-citation publication-type="other" id="h0145">Barnes MD, Hanson CL, Novilla LB, Magnusson BM, Crandall AC, Bradford G. Family-Centered Health Promotion: Perspectives for Engaging Families and Achieving Better Health Outcomes. Inq J Heal Care Organ Provision, Financ 2020;57:004695802092353. https://doi.org/10.1177/0046958020923537.</mixed-citation>
              </ref>
              <ref id="b0150">
                <label>30</label>
                <element-citation publication-type="journal" id="h0150">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Paul</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Steptoe</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Fancourt</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications</article-title>
                  <source>Lancet Reg Heal - Eur</source>
                  <volume>1</volume>
                  <year>2021</year>
                  <object-id pub-id-type="publisher-id">100012</object-id>
                  <pub-id pub-id-type="doi">10.1016/j.lanepe.2020.100012</pub-id>
                </element-citation>
              </ref>
              <ref id="b0155">
                <label>31</label>
                <mixed-citation publication-type="other" id="h0155">European Centre for Disease Prevention and Control. Catalogue of interventions addressing vaccine hesitancy. Stockholm 2017. <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/sites/default/files/documents/Catalogue-interventions-vaccine-hesitancy.pdf" id="ir040">https://www.ecdc.europa.eu/sites/default/files/documents/Catalogue-interventions-vaccine-hesitancy.pdf</ext-link> (accessed December 5, 2022).</mixed-citation>
              </ref>
              <ref id="b0160">
                <label>32</label>
                <element-citation publication-type="journal" id="h0160">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cloyes</surname>
                      <given-names>K.G.</given-names>
                    </name>
                    <name>
                      <surname>Rosenkranz</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Berry</surname>
                      <given-names>P.H.</given-names>
                    </name>
                    <name>
                      <surname>Supiano</surname>
                      <given-names>K.P.</given-names>
                    </name>
                    <name>
                      <surname>Routt</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Shannon-Dorcy</surname>
                      <given-names>K.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Essential Elements of an Effective Prison Hospice Program</article-title>
                  <source>Am J Hosp Palliat Med</source>
                  <volume>33</volume>
                  <year>2016</year>
                  <fpage>390</fpage>
                  <lpage>402</lpage>
                  <pub-id pub-id-type="doi">10.1177/1049909115574491</pub-id>
                </element-citation>
              </ref>
              <ref id="b0165">
                <label>33</label>
                <element-citation publication-type="journal" id="h0165">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jiang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Yao</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Fang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Feng</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Hayat</surname>
                      <given-names>K.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of video-led educational intervention on uptake of influenza vaccine among the elderly in western China: a community-based randomized controlled trial</article-title>
                  <source>BMC Public Health</source>
                  <volume>22</volume>
                  <year>2022</year>
                  <fpage>1128</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-022-13536-8</pub-id>
                  <pub-id pub-id-type="pmid">35668438</pub-id>
                </element-citation>
              </ref>
              <ref id="b0170">
                <label>34</label>
                <element-citation publication-type="journal" id="h0170">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abascal Miguel</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Lopez</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Sanders</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Skinner</surname>
                      <given-names>N.A.</given-names>
                    </name>
                    <name>
                      <surname>Johnston</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Vosburg</surname>
                      <given-names>K.B.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluating the impact of a linguistically and culturally tailored social media ad campaign on COVID-19 vaccine uptake among indigenous populations in Guatemala: a pre/post design intervention study</article-title>
                  <source>BMJ Open</source>
                  <volume>12</volume>
                  <year>2022</year>
                  <fpage>e066365</fpage>
                </element-citation>
              </ref>
            </ref-list>
            <sec id="s0075" sec-type="supplementary-material">
              <label>Appendix A</label>
              <title>Supplementary material</title>
              <p id="p0145">The following are the Supplementary data to this article:<supplementary-material content-type="local-data" id="m0005"><caption><title>Supplementary data 1</title></caption><media xlink:href="mmc1.docx"/></supplementary-material>
</p>
            </sec>
            <sec sec-type="data-availability" id="da005">
              <title>Data availability</title>
              <p id="p0025">Data will be made available on request.</p>
            </sec>
            <ack id="ak005">
              <title>Acknowledgments</title>
              <p id="p0135">We would like to thank the following individuals who assisted with recruitment: Jennifer Simms at Collins Bay Institution, Trevor McCuaig at Millhaven Institution, Tim Ankers at Joyceville Institution, and Crystal Thompson at Joyceville Institution. We would also like to thank all of the study participants who generously shared their time.</p>
            </ack>
            <fn-group>
              <fn id="s0070" fn-type="supplementary-material">
                <label>Appendix A</label>
                <p id="p0140">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2023.01.040" id="ir005">https://doi.org/10.1016/j.vaccine.2023.01.040</ext-link>.</p>
              </fn>
            </fn-group>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
